ESCs/iPSCs

A recent article from the laboratory of Huang‐Tian Yang (University of Chinese Academy of Sciences, Shanghai, China) explored

There exist various pluripotent states along with early embryonic development in mammals: from totipotency to naïve pluripotency to primed pluripotency. While these pluripotent stem cell populations can both self-renew and differentiate into cells representative of the three germ layers, studies have not made it clear that each cell types displays a unique epigenetic profile.

hnRNP‐K bindS at regions that overlap binding sites for crucial transcription factors and histone modifications associated with permissive chromatin

Given the lack of effective pharmaceutical approaches to the treatment of the progressive muscle disorder dysferlinopathy, researchers led by Yuko Kokubu and Hidetoshi Sakurai (Kyoto University, Japan) sought to use screen myocytes from induced pluripotent stem cells derived from a dysferlinopathy patient (Miyoshi myopathy).

Cell line‐specific differences and embryoid body maintenance methods contribute to the differing abilities of hPSCs to produce laminated retinal tissue

N-cadherin positive hPSCs function in the initiation and establishment of pluripotency and have now been postulated as human pluripotent “founder” cells

A recent STEM CELLS article from the laboratories of Xuemei Fu and Yan

New findings suggest that the Sympk scaffold protein interacts with Oct4 to promote self‐renewal and pluripotency in mouse ESCs and preserve genome integrity

Recently, researchers from the labs of Anshul Kundaje and

Researchers develop a new clinically relevant protocol to differentiate hPSCs into cardiovascular progenitors that can generate cardiomyocytes in vivo